Daugela Povilas, Cicciù Marco, Saulacic Nikola
Department of Maxillofacial Surgery, Lithuanian University of Health Sciences, Kaunas Lithuania.
Human Pathology Department, Messina University, Messina Italy.
J Oral Maxillofac Res. 2016 Sep 9;7(3):e15. doi: 10.5037/jomr.2016.7315. eCollection 2016 Jul-Sep.
The purpose of the present study was to systematically review the literature on the surgical regenerative treatment of the peri-implantitis and to determine an effective therapeutic predictable option for their clinical management.
The study searched MEDLINE and EMBASE databases from 2006 to 2016. Clinical human studies that had reported changes in probing depth (PD) and/or bleeding on probing (BOP) and/or radiologic marginal bone level (RBL) changes after peri-implantitis surgical treatment at 12-month follow-up or longer were included accordingly to PRISMA guidelines.
The initial search obtained 883 citations. After screening and determination of eligibility, 18 articles were included in the review. The meta-analysis of selected studies revealed that the weighted mean RBL fill was 1.97 mm (95% confidence interval [CI] = 1.58 to 2.35 mm), PD reduction was 2.78 mm (95% CI = 2.31 to 3.25 mm), and BOP reduced by 52.5% (95% CI = 41.6 to 63.1%). Defect fill in studies using and not using barrier membranes for graft coverage was 1.86 mm (95% CI = 1.36 to 2.36 mm) and 2.12 mm (95% CI = 1.46 to 2.78 mm) correspondingly. High heterogeneity among the studies regarding defects morphology, surgical protocols, and selection of biomaterials were found.
All included studies underlined an improvement of clinical conditions after the surgical regenerative treatment of peri-implantitis, however, there is a lack of scientific evidence in the literature regarding the superiority of the regenerative versus non-regenerative surgical treatment. The presence of a barrier membrane or submergence in the regenerative procedure does not seem to be fundamental in order to obtain clinical success of the surgery.
本研究旨在系统回顾种植体周围炎手术再生治疗的相关文献,并确定一种有效的、可预测的临床治疗方案。
本研究检索了2006年至2016年的MEDLINE和EMBASE数据库。根据PRISMA指南,纳入了在种植体周围炎手术治疗后12个月或更长时间随访时报告了探诊深度(PD)和/或探诊出血(BOP)变化和/或放射学边缘骨水平(RBL)变化的临床人体研究。
初步检索获得883篇文献。经过筛选和确定纳入标准,18篇文章被纳入本综述。对所选研究的荟萃分析显示,加权平均RBL填充量为1.97毫米(95%置信区间[CI]=1.58至2.35毫米),PD减少2.78毫米(95%CI=2.31至3.25毫米),BOP减少52.5%(95%CI=41.6至63.1%)。使用和未使用屏障膜覆盖植骨的研究中,缺损填充量分别为1.86毫米(95%CI=1.36至2.36毫米)和2.12毫米(95%CI=1.46至2.78毫米)。研究发现,在缺损形态、手术方案和生物材料选择方面存在高度异质性。
所有纳入研究均强调种植体周围炎手术再生治疗后临床状况有所改善,然而,文献中缺乏关于再生手术与非再生手术治疗优越性的科学证据。在再生手术中,屏障膜的存在或植入似乎并非获得手术临床成功的关键因素。